Predicate Devices

K034019, K051991, K043502, K070996, K033389, K053501, K093927, K072196

Reference Devices

Not Found

AI/ML (Artificial Intelligence / Machine Learning)

No
The 510(k) summary describes a standard medical catheter and does not mention any AI or ML components, image processing, or data analysis that would typically indicate the presence of such technology.

Therapeutic

Yes
The device is described as "intended for short or long term peripheral access to the central venous system for intravenous therapy and blood sampling," which are medical interventions aimed at improving or managing a patient's health condition.

Diagnostic

No

The device is a catheter for intravenous therapy, blood sampling, and contrast media injection. It is not described as being used for diagnosis, but rather for accessing the central venous system for various medical procedures.

SaMD (Software as a Medical Device)

No

The device description clearly states it is a physical catheter (PowerPICC® SV catheters) available in different lumen configurations, provided in sterile kits, and mentions physical components like extension legs, luer hubs, and junctions. This indicates it is a hardware medical device, not software-only.

IVD (In Vitro Diagnostic)

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

Intended Use: The intended use clearly states the device is for "peripheral access to the central venous system for intravenous therapy and blood sampling," "power injection of contrast media," and "central venous pressure monitoring." These are all procedures performed on the patient's body, not on samples taken from the patient in vitro (outside the body).
Device Description: The description details a catheter, which is a physical device inserted into the body.
Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) or providing diagnostic information based on such analysis.

IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device's function is to provide access to the central venous system for therapeutic and monitoring purposes, not to analyze samples for diagnosis.

PCCP (Predetermined Change Control Plan) Authorized

N/A

Overview

Intended Use / Indications for Use

The PowerPICC® SV catheters are intended for short or long term peripheral access to the central venous system for intravenous therapy and blood sampling.

The PowerPICC® SV catheter is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, blood sampling, power injection of contrast media, and allows for central venous pressure monitoring. For central venous pressure monitoring, it is recommended that a catheter lumen of 20 gauge or larger be used.

Catheter Size Maximum Flow Rate 3 F Single Lumen 1 mL/sec 4 F Dual Lumen 2.5 mL/sec

Product codes (comma separated list FDA assigned to the subject device)

LJS

Device Description

The subject PowerPICC® SV catheters are members of Bard Access Systems' PowerPICC® series of power injectable catheters. The PowerPICC® SV catheters are available in 3F single lumen and 4F dual lumen configurations. The catheter extension leg, luer hub and junction are printed with description markings to facilitate proper use of the device. The PowerPICC® SV catheters are provided in sterile kit configurations.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

central venous system

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Verification and validation activities were designed and performed to demonstrate that the subject PowerPICC® SV catheters met predetermined performance specifications. Tests were performed on sterilized, finished devices. The following guidance documents and standards in conjunction with in-house protocols were used to determine appropriate methods for evaluating the performance of the device:
• Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters, March 16, 1995
• ISO 10555-1:2009, Sterile, single-use intravascular catheters, Part 1. General requirements
• BS/EN/ISO 10555-3:1996/Cor 1:2002, Sterile, single-use intravascular catheters, Part 3. Central venous catheters
• AAMI/ANSI/ISO 10993-1:2009, Biological Evaluation of Medical Devices Part 1: Evaluation and Testing, and the FDA Modified ISO 10993 Test Profile
• AAMI/ANSI/ISO 10993-7:2008, Biological Evaluation of Medical Devices Part 7: Ethylene Oxide Sterilization Results
• AAMI/ANSI/ISO 11135:2007, Sterilization of Healthcare Products Ethylene oxide -- Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices

The subject PowerPICC® SV catheters met all predetermined acceptance criteria derived from the above mentioned references. Design validation was conducted on the subject PowerPICC® SV configuration and yielded acceptable results.

Risk management, including a failure modes and effects analysis (FMEA), of the subject device was conducted in accordance with ISO 14971:2007, Medical Devices - Risk Management for Medical Devices. No new types of safety or efficacy questions were identified for the subject PowerPICC® SV catheters.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K034019, K051991, K043502, K070996, K033389, K053501, K093927, K072196

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

Regulation Number and Section

§ 880.5970 Percutaneous, implanted, long-term intravascular catheter.

(a)
Identification. A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design.(b)
Classification. Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.”

Summary

0

Image /page/0/Picture/0 description: The image shows the logo for BARD ACCESS SYSTEMS. The word "BARD" is in large, bold, sans-serif font, with a unique design where the letters are interconnected. Below "BARD" is the text "ACCESS SYSTEMS" in a smaller, sans-serif font.

.

:
…

K102159 NOV 1 7 2010

510(k) Summary 21 CFR 807.92(a)

PowerPICC® SV Catheter

| General
Provisions | Submitter Name:
Address: | Bard Access Systems, Inc.
605 North 5600 West
Salt Lake City, UT 84116 |
|-----------------------|----------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | Contact Person: | Jessica Agnello |
| | Telephone Number:
Fax Number:
Date of Preparation: | Regulatory Affairs Specialist
(801) 522-5651
(801) 522-5425
November 4, 2010 |
| Subject
Device | Trade Name:
Common Name:
Classification Name: | PowerPICC® SV Catheter
Peripherally Inserted Central Catheter (PICC)
Percutaneous, implanted, long-term intravascular
catheter
LJS, 21 CFR § 880.5970 Class II |
| Predicate
Devices | Trade Name:
Classification Name: | Poly Per-Q-Cath® PICC Catheter
Percutaneous, implanted, long-term intravascular
catheter |
| | Premarket Notification:
Manufacturer: | LJS, 21 CFR §880.5970 Class II
K034019, K051991
Bard Access Systems, Inc. |
| | Trade Name:
Classification Name: | 6F Triple Lumen Poly Per-Q-Cath® PICC Catheter
Percutaneous, implanted, long-term intravascular
catheter |
| | Premarket Notification:
Manufacturer: | LJS, 21 CFR §880.5970 Class II
K043502, K051991
Bard Access Systems, Inc. |
| | Trade Name:
Classification Name: | 4F Single Lumen PowerPICC® Catheter
Percutaneous, implanted, long-term intravascular
catheter, |
| | Premarket Notification:
Manufacturer: | LJS, 21 CFR §880.5970 Class II
K070996
Bard Access Systems, Inc |
| | Trade Name:
Classification Name: | 5F Single Lumen PowerPICC® Catheter
Percutaneous, implanted, long-term intravascular
catheter, |
| | Premarket Notification:
Manufacturer: | LJS, 21 CFR §880.5970 Class II
K033389, K051991
Bard Access Systems, Inc |

:5

·

1

Trade Name:	6F Triple Lumen PowerPICC® Catheter
Classification Name:	Percutaneous, implanted, long-term intravascular catheter,
LJS, 21 CFR §880.5970 Class II
Premarket Notification:	K053501, K051991
Manufacturer:	Bard Access Systems, Inc
Trade Name:	PowerLine® Catheters
Classification Name:	Percutaneous, implanted, long-term intravascular catheter,
LJS, 21 CFR §880.5970 Class II
Premarket Notification:	K093927
Manufacturer:	Bard Access Systems, Inc
Trade Name:	Morpheus® CT PICC Catheter
Classification Name:	Percutaneous, implanted, long-term intravascular catheter,
LJS, 21 CFR §880.5970 Class II
Premarket Notification:	K072196
Manufacturer:	AngioDynamics, Inc
Device Description	The subject PowerPICC® SV catheters are members of Bard Access
Systems' PowerPICC® series of power injectable catheters. The
PowerPICC® SV catheters are available in 3F single lumen and 4F dual
lumen configurations. The catheter extension leg, luer hub and junction are
printed with description markings to facilitate proper use of the device.
The PowerPICC® SV catheters are provided in sterile kit configurations.
Intended Use	The PowerPICC® SV catheters are intended for short or long term peripheral
access to the central venous system for intravenous therapy and blood
sampling.
Indications For Use	The PowerPICC® SV catheter is indicated for short or long-term peripheral
access to the central venous system for intravenous therapy, blood sampling,
power injection of contrast media, and allows for central venous pressure
monitoring. For central venous pressure monitoring, it is recommended that a
catheter lumen of 20 gauge or larger be used.
	Catheter Size Maximum Flow Rate 3 F Single Lumen 1 mL/sec 4 F Dual Lumen 2.5 mL/sec
Technological Characteristics	Technological characteristics of the subject PowerPICC® SV catheters are
equivalent with respect to the basic catheter design and function to those of
the predicate Poly Per-Q-Cath® Catheters. Technical characteristics based
on the subject device's power injection capabilities are comparable to the
predicate 4F SL PowerPICC® catheter and the Morpheus® CT PICC
catheter. Differences do not raise any new questions regarding safety and

:

.

the submit the state of the state of the states and

2

| Safety &
Performance
Tests | Verification and validation activities were designed and performed to demonstrate that the subject PowerPICC® SV catheters met predetermined performance specifications. Tests were performed on sterilized, finished devices. The following guidance documents and standards in conjunction with in-house protocols were used to determine appropriate methods for evaluating the performance of the device:
• Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters, March 16, 1995
• ISO 10555-1:2009, Sterile, single-use intravascular catheters, Part 1. General requirements
• BS/EN/ISO 10555-3:1996/Cor 1:2002, Sterile, single-use intravascular catheters, Part 3. Central venous catheters
• AAMI/ANSI/ISO 10993-1:2009, Biological Evaluation of Medical Devices Part 1: Evaluation and Testing, and the FDA Modified ISO 10993 Test Profile
• AAMI/ANSI/ISO 10993-7:2008, Biological Evaluation of Medical Devices Part 7: Ethylene Oxide Sterilization Results
• AAMI/ANSI/ISO 11135:2007, Sterilization of Healthcare Products Ethylene oxide -- Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices |
|------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | The subject PowerPICC® SV catheters met all predetermined acceptance criteria derived from the above mentioned references. Design validation was conducted on the subject PowerPICC® SV configuration and yielded acceptable results. |
| | Risk management, including a failure modes and effects analysis (FMEA), of the subject device was conducted in accordance with ISO 14971:2007, Medical Devices - Risk Management for Medical Devices. No new types of safety or efficacy questions were identified for the subject PowerPICC® SV catheters. |
| Summary of
Substantial
Equivalence | Based on the indications for use, technological characteristics, and safety and performance testing, the subject PowerPICC® SV catheters met the minimum requirements for its intended use/indications for use and is substantially equivalent in design, materials, sterilization, principles of operation and indications for use to current commercially available catheters/cited predicates. |

.

:

7

.

3

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/3/Picture/1 description: The image shows a logo for the Department of Health & Human Services USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. Inside the circle is a stylized symbol composed of three curved lines that resemble a human figure or abstract design. The logo is black and white and appears to be a scanned or printed image.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Ms. Jessica Agnello Regulatory Affairs Specialist C.R. Bard, Incorporated 605 North 5600 West Salt Lake City, Utah 84116

NOV . 1 7 2010

Re: K102159

Trade/Device Name: PowerPICC® SV Catheter Regulation Number: 21 CFR 880.5970 Regulation Name: Percutaneous, Implanted, Long-Term Intravascular Catheter Regulatory Class: II Product Code: LJS Dated: November 4, 2010 Received: November 5, 2010

Dear Ms. Agnello:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

4

Page 2- Ms. Agnello

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to

http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely vours.

I. Hata for

Anthony D. Watson, B.S., M.S., M.B.A. Director

Division of Anesthesiology, general Hospital, Infection Control and dental Devices Office of Device Evaluation Center for Devices and

Radiological Health

Enclosure

5

Indications for Use

NOV 1 7 2010

510(k) Number (if known):

K102159

Device Name:

PowerPICC® SV Catheter

Indications for Use:

The PowerPICC® SV catheter is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, blood sampling, power injection of contrast media, and allows for central venous pressure monitoring. For central venous pressure monitoring, it is recommended that a catheter lumen of 20 gauge or larger be used.

Catheter Size	Maximum Flow Rate
3 F Single Lumen	1 mL/sec
4 F Dual Lumen	2.5 mL/sec

V Prescription Use (Part 21 CFR §801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR §801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED

Concurrence of CDRH, Office of Device Evaluation (ODE)

Rhd C. Chape 11/17/10

Page 1 of 1 (Division Sinn-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices

510(k) Numbar.

4